Tavakoli Azadeh, Flanagan Judith Louise
School of Optometry and Vision Science, University of New South Wales, Sydney, 2052, Australia.
Brien Holden Vision Institute, Sydney, 2052, Australia.
Antibiotics (Basel). 2019 Jun 30;8(3):88. doi: 10.3390/antibiotics8030088.
Dry eye disease (DED) is one of the most frequent presentations to optometrists with over 16 million US adults (6.8% of adult population) diagnosed as having this disorder. The majority of associated marketed products offer relief from symptomatology but do not address aetiology. DED harbours many distinguishing features of a chronic inflammatory disorder. The recent explosion in human microbiome research has sparked interest in the ocular microbiome and its role in the preservation and extension of ocular surface health and in the contribution of the gut microbiome to chronic systemic inflammation and associated "Western life-style" diseases. With a significant lack of success for many patients using currently available DED treatments, in this era of the microbiome, we are interested in exploring potential novel therapies that aim to reconstitute healthy bacterial communities both locally and distally (in the gut) as a treatment for DED. Although this direction of investigation is in its infancy, burgeoning interest makes such a review timely. This paper considers a number of studies into the use functional foods and associated products to ameliorate dry eye.
干眼病(DED)是验光师最常接诊的病症之一,超过1600万美国成年人(占成年人口的6.8%)被诊断患有这种疾病。大多数相关的上市产品只能缓解症状,而不能解决病因。DED具有慢性炎症性疾病的许多显著特征。最近人类微生物组研究的爆发引发了人们对眼部微生物组及其在维持和扩展眼表健康中的作用,以及肠道微生物组对慢性全身炎症和相关“西方生活方式”疾病的贡献的兴趣。由于许多患者使用目前可用的DED治疗方法效果不佳,在这个微生物组时代,我们有兴趣探索潜在的新疗法,旨在在局部和远端(肠道)重建健康的细菌群落,作为DED的一种治疗方法。尽管这一研究方向尚处于起步阶段,但迅速增长的兴趣使得这样的综述很及时。本文考虑了一些关于使用功能性食品和相关产品改善干眼症的研究。